(NASDAQ: ICLR) Icon's forecast annual revenue growth rate of 6.28% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Icon's revenue in 2024 is $8,231,984,000.On average, 5 Wall Street analysts forecast ICLR's revenue for 2024 to be $711,934,185,235, with the lowest ICLR revenue forecast at $702,452,998,683, and the highest ICLR revenue forecast at $716,099,629,964. On average, 5 Wall Street analysts forecast ICLR's revenue for 2025 to be $763,672,749,376, with the lowest ICLR revenue forecast at $744,600,158,760, and the highest ICLR revenue forecast at $776,417,465,711.
In 2026, ICLR is forecast to generate $817,632,696,622 in revenue, with the lowest revenue forecast at $789,276,120,329 and the highest revenue forecast at $840,191,484,508.